AI assistant
ABBOTT LABORATORIES — Director's Dealing 2012
Mar 2, 2012
29777_dirs_2012-03-02_164e4570-6f31-406b-a569-63f6c3aaa6d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-02-29
Reporting Person: FREYMAN THOMAS C (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-29 | Common shares without par value | F | 27207 | $57.04 | Disposed | 398177 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 1028 | Indirect |
| Common shares without par value | 15000 | Indirect |
| Common shares without par value | 1941 | Indirect |
| Common shares without par value | 1941 | Indirect |
| Common shares without par value | 1941 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012.
F2: Held in the Annette Newton-Freyman 1994 Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
F3: The reporting person disclaims beneficial ownership of all securities held by his daughter.
F4: These shares are held in an irrevocable trust for the benefit of the reporting person's son. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities.